Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Weight

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Urology|June 30, 2022
Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer When Treated by Radical Cystectomy With or Without Neoadjuvant ChemotherapyTarik Benidir, Zaeem Lone, Ao Zhang, et al.
Urology|March 25, 2023
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSATarik Benidir, Zaeem Lone, Andrew Wood, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Urologic Oncology|October 5, 2025
IsoPSA density improves risk stratification and biopsy decision-making for clinically significant prostate cancerBetty Wang, Tarik Benidir, Kristina Dortche, et al.
Urologic Oncology|January 10, 2026
Location matters: Reduced detection of csPCa in transition zone versus peripheral zone PI-RADS lesionsAndrew M Wood, Sabrina L Noyes, Jennifer Bullen, et al.
Urology Practice|January 8, 2026
Histologic Patterns and Germline Genetic Testing Outcomes in Presumed Sporadic Bilateral Renal MassesKieran Lewis, Jason M Scovell, Eran N Maina, et al.
Histopathology|October 16, 2025
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'Jesse K McKenney, James D Brooks, Jane K Nguyen, et al.
BJU International|December 10, 2024
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal functionEiftu S Haile, Zaeem Lone, David Shin, et al.
Scientific Reports|April 17, 2023
Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomyNityam Rathi, Worapat Attawettayanon, Yosuke Yasuda, et al.
BJUI Compass|March 2, 2026
Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal massesAkira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Urology|June 30, 2022
Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer When Treated by Radical Cystectomy With or Without Neoadjuvant ChemotherapyTarik Benidir, Zaeem Lone, Ao Zhang, et al.
Urology|March 25, 2023
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSATarik Benidir, Zaeem Lone, Andrew Wood, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Urologic Oncology|October 5, 2025
IsoPSA density improves risk stratification and biopsy decision-making for clinically significant prostate cancerBetty Wang, Tarik Benidir, Kristina Dortche, et al.
Urologic Oncology|January 10, 2026
Location matters: Reduced detection of csPCa in transition zone versus peripheral zone PI-RADS lesionsAndrew M Wood, Sabrina L Noyes, Jennifer Bullen, et al.
Urology Practice|January 8, 2026
Histologic Patterns and Germline Genetic Testing Outcomes in Presumed Sporadic Bilateral Renal MassesKieran Lewis, Jason M Scovell, Eran N Maina, et al.
Histopathology|October 16, 2025
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'Jesse K McKenney, James D Brooks, Jane K Nguyen, et al.
BJU International|December 10, 2024
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal functionEiftu S Haile, Zaeem Lone, David Shin, et al.
Scientific Reports|April 17, 2023
Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomyNityam Rathi, Worapat Attawettayanon, Yosuke Yasuda, et al.
BJUI Compass|March 2, 2026
Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal massesAkira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
Pageof 18